Search hospitals > Texas > Houston
Houston Methodist Hospital
Claim this profileHouston, Texas 77030
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Stroke
Conducts research for Lymphoma
Conducts research for Heart Failure
821 reported clinical trials
101 medical researchers
Summary
Houston Methodist Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Thyroid Cancer, Breast Cancer, Stroke, Lymphoma, Heart Failure and other specialties. Houston Methodist Hospital is involved with conducting 821 clinical trials across 994 conditions. There are 101 research doctors associated with this hospital, such as Jun Zhang, Carlos Ramos, MD, Maen Abdelrahim, MD, and Rayne H. Rouce.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 positive
ER positive
Top PIs
Jun ZhangHouston Methodist Hospital5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
28 reported clinical trials
43 drugs studied
Carlos Ramos, MDHouston Methodist Hospital2 years of reported clinical research
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
12 reported clinical trials
16 drugs studied
Maen Abdelrahim, MDHouston Methodist2 years of reported clinical research
Studies Thyroid Cancer
Studies Stomach Cancer
10 reported clinical trials
22 drugs studied
Rayne H. RouceTexas Children's Hospital5 years of reported clinical research
Studies Lymphoma
Studies Acute Lymphoblastic Leukemia
9 reported clinical trials
20 drugs studied
Clinical Trials running at Houston Methodist Hospital
Breast Cancer
Prostate Cancer
Ovarian Cancer
Lung Cancer
Multiple Myeloma
Thyroid Cancer
Breast cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Cardiomyopathy
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Houston Methodist Hospital?
Houston Methodist Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Thyroid Cancer, Breast Cancer, Stroke, Lymphoma, Heart Failure and other specialties. Houston Methodist Hospital is involved with conducting 821 clinical trials across 994 conditions. There are 101 research doctors associated with this hospital, such as Jun Zhang, Carlos Ramos, MD, Maen Abdelrahim, MD, and Rayne H. Rouce.
Where is Houston Methodist Hospital located?
Houston Methodist Hospital's main campus is situated at 6565 Fannin Street, within the Texas Medical Center in Houston, Texas. For access, take I-69/US-59 South towards downtown Houston, exit at Fannin Street, turn right, and proceed for about 1 mile. The hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
Houston Methodist Hospital provides financial assistance for uninsured or underinsured patients unable to afford medically necessary care, including emergency services. For details on their financial assistance policy or to apply, contact the hospital at (713) 790-3311 or visit their website. Ensure you have your ID card, insurance card, and driver's license when visiting Admitting/Registration.
What insurance does Houston Methodist Hospital accept?
Houston Methodist Hospital accepts a wide range of insurance plans, including EPO, HMO, Indemnity, Medicare HMO & PPO, POS, PPO, Premier Care Network, and Premier Care Network Plus Multi-Tier. It is in-network with several insurance providers such as Aetna, Blue Cross and Blue Shield of Texas, Cigna, Humana, and United Healthcare, among others. To determine individual coverage, patients are advised to contact their insurance carrier directly.
What awards or recognition has Houston Methodist Hospital received?
Houston Methodist Hospital, located in Houston, Texas, has been named the Best Hospital in Texas for 12 consecutive years by U.S. News & World Report. It boasts national rankings in 10 specialties and high-performing scores in 18 out of 21 common conditions and procedures. The hospital is also celebrated for its innovative contributions to healthcare, including FDA clearance for a novel craniomaxillofacial surgery software and significant research achievements in treating glioblastomas, earning the 2022 Houston Inno Fire Award for innovation in health care and life sciences.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.